ARGATROBAN (GlaxoSmithKline LLC)


Welcome to the PulseAid listing for the ARGATROBAN drug offered from GlaxoSmithKline LLC. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline LLC
NON-PROPRIETARY NAME: argatroban
SUBSTANCE NAME: ARGATROBAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2000-11-28
END MARKETING DATE: 0000-00-00


ARGATROBAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionARGATROBAN from GlaxoSmithKline LLC
LABELER NAME: GlaxoSmithKline LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2000-11-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0007-4407_334cd1c6-10af-4aaf-abfd-603b6eb3a832
PRODUCT NDC: 0007-4407
APPLICATION NUMBER: NDA020883

Other ARGATROBAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eagle Pharmaceuticals, Inc.Argatroban
Fresenius Kabi USA, LLCArgatroban
Gland Pharma LimitedArgatroban
GlaxoSmithKline LLCARGATROBAN
Hospira, Inc.Argatroban
Par Pharmaceutical, Inc.Argatroban
Sandoz IncArgatroban
Teva Parenteral Medicines, Inc.Argatroban
West-Ward Pharmaceuticals CorpArgatroban